Alzheimer’s disease (AD) in the most common neurodegenerative disorder in the world, affecting over 35 million people. AD is characterized by a progressive loss of memory and cognitive function that eventually robs patients of the ability to perform basic daily functions. However, currently approved therapies are not disease modifying and only provide limited benefits. Pathologically, the brains of AD patients exhibit two hallmark protein aggregates, amyloid plaques and neurofibrillary tangles composed of the protein tau.An additional pathological hallmark of Alzheimer’s disease is the presence of reactive microglia that surround plaques, contributing to a chronic proinflammatory state within the brain which exacerbates many of the other...
Alzheimer's disease is an important public concern with rising prevalence across the globe. While ma...
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
Immune activation and inflammation, likely triggered by amyloid-beta (A\u3b2) deposition, play a rem...
The innate immune system is strongly implicated in the pathogenesis of Alzheimer's disease (AD). In ...
Alzheimer’s Disease is the most common cause in the world of progressive cognitive decline. Although...
Alzheimer’s disease (AD) is a common neurodegenerative disorder that is extensively researched, sinc...
AbstractThe Alzheimer's Association's Research roundtable met in April 2015 to explore the role of n...
This study examines the link between peripheral immune changes in perpetuation of the Alzheimer's di...
Alzheimer’s Disease is the most common form of dementia and is the fifth-leading cause of death in p...
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreti...
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cy...
Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation, tau pathology and neuro...
INTRODUCTION: In Alzheimer's disease, accumulation and pathological aggregation of amyloid β-peptide...
The ultimate cause of Alzheimer's disease (AD) is still unknown and no disease-modifying treatment e...
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have been driven la...
Alzheimer's disease is an important public concern with rising prevalence across the globe. While ma...
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
Immune activation and inflammation, likely triggered by amyloid-beta (A\u3b2) deposition, play a rem...
The innate immune system is strongly implicated in the pathogenesis of Alzheimer's disease (AD). In ...
Alzheimer’s Disease is the most common cause in the world of progressive cognitive decline. Although...
Alzheimer’s disease (AD) is a common neurodegenerative disorder that is extensively researched, sinc...
AbstractThe Alzheimer's Association's Research roundtable met in April 2015 to explore the role of n...
This study examines the link between peripheral immune changes in perpetuation of the Alzheimer's di...
Alzheimer’s Disease is the most common form of dementia and is the fifth-leading cause of death in p...
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreti...
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cy...
Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation, tau pathology and neuro...
INTRODUCTION: In Alzheimer's disease, accumulation and pathological aggregation of amyloid β-peptide...
The ultimate cause of Alzheimer's disease (AD) is still unknown and no disease-modifying treatment e...
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have been driven la...
Alzheimer's disease is an important public concern with rising prevalence across the globe. While ma...
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
Immune activation and inflammation, likely triggered by amyloid-beta (A\u3b2) deposition, play a rem...